The Federal Trade Commission has officially inked a second settlement with one of the "Big Three" pharmacy benefit managers in an ongoing legal battle over insulin prices.
Source: FierceHealthcare
You may also like
Knee Pain? Ragged Cartilage? Research Suggests...
Lawmakers Look To Make Abortion Shield Laws Less...
HistoSonics wins Europe’s CE mark for...
Medtronic recalls heart valve delivery catheter for...
CVS Caremark reaches settlement with FTC over insulin...
HCA cuts 2026 earnings forecast on insurance coverage...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.